The use of sodium-glucose transporter (SGLT-2) inhibitors can reduce the progression of chornic kidney disease in diabetics and non-diabetics

Article name: The Proximal Tubule in the Pathophysiology of the Diabetic Kidney Link DOI This article was published in the American Journal of Physiology-Regulatory, Integrative and Comparative Physiology

Article name: Empagliflozin in Patients with Chronic Kidney Disease Link DOI This article was published in the New England Journal of Medicine in 2023. It is a randomized controlled trial which compared